Studies include a Randomized Controlled Trial demonstrating
significant reduction in perceived stress for teens
NEW
YORK, April 10, 2024 /PRNewswire/ -- DarioHealth
Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the
global digital health market, announced today two new studies
published in the leading peer-reviewed journal for digital health
and medicine, Journal of Internet Medicine (JMIR), including
a Randomized Controlled Trial (RCT) demonstrating the impact of a
digital stress reduction program for teens.
Digital Tools Reduce Stress and Brooding in Teens in a
Randomized Control Trial
The first study uses the gold standard in research, a randomized
controlled clinical trial (RCT), to demonstrate the impacts of a
self-guided Digital Mental Health Intervention (DMHI) for teens.
Teens engaged in the DMHI saw significant improvements in perceived
stress, brooding and loneliness compared to the group waiting for
access, demonstrating the potential for digital stress management
programs as an effective alternative to in-person programs.
The analysis followed a group of 303 teens with elevated levels
of stress and rumination (i.e. brooding) during a 12-week period to
understand whether a digital stress management program developed
for teens provides an effective intervention.
Teens were randomly assigned to either a test group receiving a
self-guided DMHI or a control group that waited for access during
the time period of the study. The test group engaged in the DMHI
received access to various evidence-based activities drawn from
therapeutic modalities such as cognitive behavioral therapy,
positive psychology, and mindfulness. Levels of perceived stress
and brooding were assessed at 4 weeks, 8 weeks and 12 weeks in both
the test and control groups.
You can access the full study here.
Digital Engagement with Relaxation Tools and Reduction of
Stress
The second study, published in JMIR Formative Research,
examined the relationship between the use of relaxation tools such
as breathing exercises and Cognitive Behavioral Therapy (CBT)-based
videos in a digital behavioral health solution and the level of
stress reduction.
Stress levels were evaluated on a group of 490 people engaged in
Dario's digital behavioral health solution with moderate and higher
levels of stress at the beginning of a 10-week period. A
significant reduction in stress levels was observed in the first 6
weeks and that reduction was maintained through the following 4
weeks of engagement. Users who engaged in both digital CBT-based
videos and breathing exercises as a relaxation tool saw a
significant moderating effect on general levels of stress, on
perceived sense of burden and on lack of productivity,
demonstrating the impact digital relaxation tools can have for
people as part of a personalized behavioral health program.
You can access the full study here.
"Digital solutions for mental health offer tremendous value as a
convenient means of accessing proven treatment and support,
especially for those at higher risk of experiencing a mental health
need, such as people living with chronic conditions or teenagers.
Better understanding of how different components impact outcomes is
critical to helping further personalize mental health experiences
in meaningful ways, and we are thrilled to see these research
efforts published in JMIR," said Yifat Hershcovitz, PhD., Vice
President of Clinical and Scientific Affairs at Dario.
"Our latest RCT demonstrates the positive impact digital mental
health solutions can offer, in particular for teens where access to
in-person care is particularly challenging. We believe that sharing
real-world evidence is critically important as the market
increasingly looks for technology to address more than access, and
studies like this help demonstrate how digital solutions can better
impact," said Omar Manejwala, M.D.,
Chief Medical Officer.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health
company revolutionizing how people with chronic conditions manage
their health through a user-centric, multi-chronic condition
digital therapeutics platform. Dario's platform and suite of
solutions deliver personalized and dynamic interventions driven by
data analytics and one-on-one coaching for diabetes, hypertension,
weight management, musculoskeletal pain and behavioral
health.
Dario's user-centric platform offers people continuous and
customized care for their health, disrupting the traditional
episodic approach to healthcare. This approach empowers people to
holistically adapt their lifestyles for sustainable behavior
change, driving exceptional user satisfaction, retention and
results and making the right thing to do the easy thing to do.
Dario provides its highly user-rated solutions globally to
health plans and other payers, self-insured employers, providers of
care and consumers. To learn more about Dario and its digital
health solutions, or for more information, visit
http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. related thereto contain or may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Statements that
are not statements of historical fact may be deemed to be
forward-looking statements. For example, the Company is using
forward-looking statements in this press release when it
discusses the potential benefits of using digital solutions
for mental health and the belief that real-world evidence is
critically important as the market increasingly looks for
technology to address more than access. Without limiting the
generality of the foregoing, words such as "plan," "project,"
"potential," "seek," "may," "will," "expect," "believe,"
"anticipate," "intend," "could," "estimate" or "continue" are
intended to identify forward-looking statements. Readers are
cautioned that certain important factors may affect the Company's
actual results and could cause such results to differ materially
from any forward-looking statements that may be made in this news
release. Factors that may affect the Company's results include, but
are not limited to, regulatory approvals, product demand, market
acceptance, impact of competitive products and prices, product
development, commercialization or technological difficulties, the
success or failure of negotiations and trade, legal, social and
economic risks, and the risks associated with the adequacy of
existing cash resources. Additional factors that could cause or
contribute to differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario™ as described
herein) may differ significantly from those set forth in the
forward-looking statements. The Company undertakes no obligation to
publicly update any forward-looking statements, whether as a result
of new information, future events or otherwise, except as required
by applicable law.
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
+1-312-593-4280
DarioHealth Investor Relations Contact
Kat Parella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922
Media Contact
Scott
Stachowiak
Scott.Stachowiak@russopartnersllc.com
+1-646-942-5630
View original
content:https://www.prnewswire.com/news-releases/dario-publishes-two-new-peer-reviewed-studies-demonstrating-impact-of-digital-behavioral-health-302112901.html
SOURCE DarioHealth Corp.
